MENU
+Compare
SAFLF
Stock ticker: OTC
AS OF
Dec 10 closing price
Price
$2.20
Change
+$0.27 (+13.99%)
Capitalization
873.79M

SAFLF Safilo Group Spa Forecast, Technical & Fundamental Analysis

Safilo Group SpA makes sunglasses and prescription eyewear... Show more

SAFLF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SAFLF with price predictions
Dec 24, 2025

SAFLF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SAFLF turned positive on December 10, 2025. Looking at past instances where SAFLF's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 24 cases where SAFLF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SAFLF entered a downward trend on December 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SAFLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.823) is normal, around the industry mean (9.534). P/E Ratio (16.655) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.546). SAFLF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.776) is also within normal values, averaging (112.419).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SAFLF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Settima Strada, 15
Phone
+39 496985111
Employees
4442
Web
https://www.safilogroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMCX26.650.37
+1.41%
Nomura Emerging Markets C
NQCAX5.640.02
+0.36%
Nuveen Large Cap Value Opportunities A
LGOFX29.560.06
+0.20%
Lord Abbett Growth Opportunities F
JARIX14.56N/A
N/A
Easterly Global Real Estate I
IYHIX5.93N/A
N/A
Nomura High Income Fund Class R

SAFLF and Stocks

Correlation & Price change

A.I.dvisor tells us that SAFLF and GMED have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
GMED - SAFLF
28%
Poorly correlated
-0.38%
MYGN - SAFLF
24%
Poorly correlated
-0.15%
OFIX - SAFLF
22%
Poorly correlated
+1.13%
MROPF - SAFLF
21%
Poorly correlated
N/A
GRRMF - SAFLF
21%
Poorly correlated
N/A
More

Groups containing SAFLF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
Pharmaceuticals
category (375 stocks)
20%
Poorly correlated
+0.36%
Pharmaceuticals: Other
category (102 stocks)
18%
Poorly correlated
+0.30%